Thursday, July 19, 2012

Oral Vaccine Developed In China


Oral vaccine developed in China par powers to speed up multiple positive growth - Vaccine research a

Article by hi joiney



Oral vaccine developed in China par powers to speed up multiple positive growth - Vaccine research a - Business












Search by Author, Title or Content



Article ContentAuthor NameArticle Title









Home
Submit Articles
Author Guidelines
Publisher Guidelines
Content Feeds
RSS Feeds
FAQ
Contact Us

































Recently the National Science and Technology announced in Beijing China with independent intellectual property rights of quot oral recombinant Helicobacter pylori vaccine quot has been successfully developed and obtained a class of new drug certificate br br Learned that the vaccine has good efficacy and safety prevention of Helicobacter pylori infection rate of greater than 72 1 protection can be produced in the gastrointestinal tract of high specific antibodies Liu Yanhua Vice Minister of Science and Technology br br at a news conference said quot This is by far the world 39 s first complete Phase study of Helicobacter pylori oral vaccine quot Marked the original vaccine research has made a major breakthrough br br Before this China and some major breakthrough in vaccine development March 21 the State Food And Drug Administration formally approved AIDS Phase clinical study vaccine launched in Guangxi Also the world 39 s first diabetes oral vaccine only in recent days appeared in China Some experts are optimistic that this year 39 s vaccine R amp D has multiple positive vaccine research and development in China has entered the quot fast lane quot br br However some industry insiders believe by capital technology and other factors our scientific research institutions in vaccine development against the background of prosperity but also come a long bumpy road The face of foreign vaccine manufacturers still empty all kinds of infectious diseases Epidemic Become more complex internal oral vaccine research and development added to the uncertainty br br Long way rough industrial quot As the vaccine injections were orally inoculated with the traditional vaccination approach has many attractive advantages in comparison therefore our involvement with oral vaccine for some time as experienced Helicobacter pylori vaccine is only 15 years of research development successful it fills the birth of the field of vaccine development against stomach empty From this sense the oral vaccine vision can be expected quot Shanghai Fudan Zhangjiang Bio Medicine In an interview with Vice President Dr Su Yong Co Ltd quot Medicine Economic News quot reporters said However the quot oral vaccine to achieve domestic industrial production there are still many technical problems to be broken quot Despite the advantages of oral vaccine br br more but not all pathogens can be successfully used after the development of live attenuated oral vaccine Life Sciences Jilin University Vaccine Research Center Director Professor Kong Wei carefully told reporters quot How to improve vaccine immunogenicity is a researcher insurmountable task Not only in the mucosal surface to ensure adequate microbial survival time but also to avoid side effects balanced Both are still no precedent to follow which can be in the dark but we have reason to believe no longer far away from the dawn quot br br Interview reporter learned that in addition to the above mentioned topics the carrier materials research is also dense fog quot The use of carrier particles or nanoparticles Preparation of delivery system so popular though but full of uncertainty Like how to overcome the weaknesses of its poor water solubility and whether degradation is a very real problem quot Microbiology and Immunology Third Military Medical University Laboratory of Microbiology and Immunology Director also said quot The result is certainly encouraging but this is only the first step Long March the road ahead is still waiting to be reclaimed quot Turning to industrial br br roadblocks the three veterans are referred to the current problem of low absorption of oral vaccine It is understood researchers try to use delivery system and mucosal adhesion targeting delivery system and other methods to improve the absorption of oral vaccine quot Now the research in animals has been successful but whether it applies to the human body is unknown quot

About the Author

I am an expert from China Manufacturers, usually analyzes all kind of industries situation, such as marine gasoline generators , kipor inverter generator.












Use and distribution of this article is subject to our Publisher Guidelines

whereby the original author's information and copyright must be included.





hi joiney









RSS Feed





Report Article





Publish Article





Print Article





Add to Favorites











Article Directory
About
FAQ
Contact Us
Advanced Search
Privacy Statement
Disclaimer

GoArticles.com � 2012, All Rights Reserved.









I am an expert from China Manufacturers, usually analyzes all kind of industries situation, such as marine gasoline generators , kipor inverter generator.












Use and distribution of this article is subject to our Publisher Guidelines

whereby the original author's information and copyright must be included.









A vaccine strategy that protects against all strains of seasonal influenza and avoids the need for annual vaccination is the ultimate goal of a research collaboration between the University of Pittsburgh Center for Vaccine Research and vaccine-maker Sanofi Pasteur.
Video Rating: 0 / 5



Related Vaccine Research Articles
| How To Decorate Your Home Inexpensively | Mat: Its Uses and Importance | Sell Car To These Guys | Strong Crypto Work You Could Manage On Your Own | Freightliner Trucks and How it All Began | Muds | Things to Look for When Purchasing Prescription Glasses OnlineDiscover How | Here Is How To Take Better Photographs Now! | playground tiles

No comments:

Post a Comment